Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial

NCT06299670 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT06299670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06299670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2023
Completion date
January 30, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transfusion-dependent thalassemia